{"transactions":[{"id":736257,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:05:21.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":31000,"derivative":{"exercise_price":3.94,"exercise_date":"2027-06-15","expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001213900-26-069249","document":"marketforms-73186.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000121390026069249/marketforms-73186.xml","form_type":"4"}},{"id":1111782,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:05:13.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":24000,"derivative":{"exercise_price":3.26,"exercise_date":"2026-06-12","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001213900-25-054288","document":"marketforms-69818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000121390025054288/marketforms-69818.xml","form_type":"4"}},{"id":1485049,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T22:00:23.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":2.67,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-24-051380","document":"marketforms-66264.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000121390024051380/marketforms-66264.xml","form_type":"4"}},{"id":1862523,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T20:10:42.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":2.85,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-23-047468","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000121390023047468/ownership.xml","form_type":"4"}},{"id":2237882,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T20:10:14.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":3.5,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-22-031993","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000121390022031993/ownership.xml","form_type":"4"}},{"id":2674113,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T00:08:38.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":10.51,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-039686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000120919121039686/doc4.xml","form_type":"4"}},{"id":3113586,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T17:41:08.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":9000,"derivative":{"exercise_price":35,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-20-035850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000120919120035850/doc4.xml","form_type":"4"}},{"id":3113585,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T17:40:33.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":6676,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received in the Merger in exchange for a stock option to acquire 35,000 shares of ArTara Sub common stock for $1.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest in forty eight (48) approximately equal increments of one hundred thirty nine (139) whole Option Shares beginning on the first day of the first calendar month following December 4, 2018, and then on the first day of each of the next forty seven (47) months thereafter (each a \"Vesting Date\"), if Reporting Person has remained continuously engaged by the Issuer or any Affiliate through such Vesting Date; provided that, on the last such Vesting Date (being December 1, 2022), all of the Option Shares which had not vested by then (being not less than 139 Option Shares) will vest and become exercisable."}],"balance_after":6676,"derivative":{"exercise_price":9.18,"expiration_date":"2028-12-03","underlying":"Common Stock","underlying_shares":6676},"source":{"system":"sec-edgar","filing":"0001209191-20-035849","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000120919120035849/doc4a.xml","form_type":"4/A","original_submission_date":"2020-01-13"}},{"id":3113584,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T17:40:33.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":2861,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in the Merger in exchange for a stock option to acquire 15,000 shares of ArTara Sub common stock for $1.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred nineteen (119) of the Option Shares shall vest as of the date of the grant, and the remaining Option Shares shall vest in forty six (46) approximately equal increments of fifty nine (59) whole Option Shares beginning on the first day of the first calendar month following the Date of Grant and then on the first day of each of the next forty five (45) months thereafter (each a \"Vesting Date\"), if the Reporting Person has remained continuously engaged by the Issuer or any Affiliate through such Vesting Date; provided that, on the last such Vesting Date (being May 1, 2022), all of the Option Shares which had not vested by then (being not less than 64 Option Shares) will vest and become exercisable, and that the vesting of all then unvested Option Shares shall be accelerated upon a Change of Control."}],"balance_after":2861,"derivative":{"exercise_price":9.18,"expiration_date":"2028-07-11","underlying":"Common Stock","underlying_shares":2861},"source":{"system":"sec-edgar","filing":"0001209191-20-035849","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000120919120035849/doc4a.xml","form_type":"4/A","original_submission_date":"2020-01-13"}},{"id":3113583,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-11T17:40:33.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (\"RSUs\"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 3/24th of the shares were vested upon grant and 1/24th of the shares vest monthly thereafter, beginning on February 10, 2020. Settlement for the RSUs is deferred until the earliest to occur of (i) the Reporting Person's termination of service, (ii) death, (iii) disability and (iv) a change in control of the Issuer. In the event of a change in control of the Issuer, the RSUs will vest in full."}],"balance_after":26500,"source":{"system":"sec-edgar","filing":"0001209191-20-035849","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000120919120035849/doc4a.xml","form_type":"4/A","original_submission_date":"2020-01-13"}},{"id":3312676,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T00:15:34.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":10491,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Received in the Merger in exchange for a stock option to acquire 55,000 shares of ArTara Sub common stock for $1.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"1/48th of the shares subject to the option shall vest monthly following April 29, 2019, for so long as the Reporting Person provides continuous service to the Issuer."}],"balance_after":10491,"derivative":{"exercise_price":9.18,"expiration_date":"2029-04-28","underlying":"Common Stock","underlying_shares":10491},"source":{"system":"sec-edgar","filing":"0001209191-20-003237","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000120919120003237/doc4.xml","form_type":"4"}},{"id":3312675,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T00:15:34.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":6676,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Received in the Merger in exchange for a stock option to acquire 35,000 shares of ArTara Sub common stock for $1.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/48th of the shares subject to the option shall vest monthly following January 1, 2019, for so long as the Reporting Person provides continuous service to the Issuer."}],"balance_after":6676,"derivative":{"exercise_price":9.18,"expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":6676},"source":{"system":"sec-edgar","filing":"0001209191-20-003237","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000120919120003237/doc4.xml","form_type":"4"}},{"id":3312674,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T00:15:34.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":2861,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received in the Merger in exchange for a stock option to acquire 15,000 shares of ArTara Sub common stock for $1.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option shall vest monthly following August 1, 2018, for so long as the Reporting Person provides continuous service to the Issuer."}],"balance_after":2861,"derivative":{"exercise_price":9.18,"expiration_date":"2028-07-11","underlying":"Common Stock","underlying_shares":2861},"source":{"system":"sec-edgar","filing":"0001209191-20-003237","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000120919120003237/doc4.xml","form_type":"4"}},{"id":3312673,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T00:15:34.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":9537,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in the Merger in exchange for a stock option to acquire 50,000 shares of ArTara Sub common stock for $1.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option shall vest monthly following June 1, 2018, for so long as the Reporting Person provides continuous service to the Issuer."}],"balance_after":9537,"derivative":{"exercise_price":9.18,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":9537},"source":{"system":"sec-edgar","filing":"0001209191-20-003237","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000120919120003237/doc4.xml","form_type":"4"}},{"id":3312672,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37705,"kind":"person","name":"Solomon Michael Edward","position":1,"cik":"0001799320","reported_name":"Solomon Michael Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-14T00:15:34.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (\"RSUs\"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 50% of the shares vest on January 10, 2021 and 1/24th of the shares vest monthly thereafter. Settlement for the RSUs is deferred until the earliest to occur of (i) the Reporting Person's termination of service, (ii) death, (iii) disability and (iv) a change in control of the Issuer. In the event of a change in control of the Issuer, the\nRSUs will vest in full."}],"balance_after":26500,"source":{"system":"sec-edgar","filing":"0001209191-20-003237","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799320/000120919120003237/doc4.xml","form_type":"4"}}]}